化合物GGTI-2133 T24088
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
50 mg | 191102-79-1 | ¥19,800.00 | 询底价 |
25 mg | 191102-79-1 | ¥14,800.00 | 询底价 |
1 mg | 191102-79-1 | ¥3,300.00 | 询底价 |
100 mg | 191102-79-1 | ¥27,300.00 | 询底价 |
5 mg | 191102-79-1 | ¥7,510.00 | 询底价 |
10 mg | 191102-79-1 | ¥9,870.00 | 询底价 |
Product Introduction
Bioactivity
英文名: GGTI-2133
描述: GGTI-2133 是一种有效的仿肽基香叶基转移酶 I 型抑制剂(GGTase I),IC50值为38 nM。GGTI-2133 可抑制小鼠实验性哮喘中炎症细胞向气道的侵袭。
体外活性: BSM tissues isolated from the repeatedly antigen-challenged mice were cultured for 48 h in the absence or presence of GGTI-2133. Under these conditions, the putative geranylgeranylated RhoA was decreased in a GGTI-2133 concentration-dependent manner. The in vitro incubation with GGTI-2133 also inhibited BSM hyperresponsiveness induced by antigen exposure. These findings suggest that GGTI-2133 inhibits antigen-induced BSM hyperresponsiveness, probably by reducing downstream signal transduction of RhoA.[1]
体内活性: Animals also were treated with GGTI-2133 (5 mg/kg; i.p.; once a day; mice with experimental asthma) during the antigen inhalation period. Repeated antigen inhalation caused a BSM hyperresponsiveness to acetylcholine with the increased expressions of RhoA and the anti-farnesyl-positive 21-kDa proteins, probably geranylgeranylated RhoA. The in vivo GGTI-2133 treatments significantly inhibited BSM hyperresponsiveness induced by antigen exposure.[1]
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 50 mg/mL (109.52 mM)
关键字: GGTI-2133
相关产品: OU749 | Miglustat hydrochloride | Arglabin | 7beta-Methoxyrosmanol | Testosterone propionate | 3,5-Dinitrocatechol | Entacapone acid | 3-O-Methyltolcapone D7 | T863 | Tectol
相关库: Bioactive Compounds Library Max | Inhibitor Library | Bioactive Compound Library
化合物GGTI-2133 T24088信息由TargetMol中国为您提供,如您想了解更多关于化合物GGTI-2133 T24088报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途